Skip to content

GREEN PLANET BIOENGINEERING CO., LTD.: 10-Q filed 2012-11-14

What GREEN PLANET BIOENGINEERING CO., LTD. reported in its quarterly report filed 2012-11-14 (fiscal Q3 2012): 17 published measures, 48 facts as tagged in accession 0001354488-12-005888.

This filing

Form
10-Q (quarterly report)
Filed
2012-11-14
Fiscal period
fiscal Q3 2012
Accession
0001354488-12-005888 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GREEN PLANET BIOENGINEERING CO., LTD. filings.

Reported measures

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-09-3024,016USD
At 2011-12-31178,589USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-09-30-22,591USD
At 2011-12-31-177,921USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-09-300USD
At 2011-12-31668USD
At 2011-09-30668USD
At 2010-12-31668USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-6,821USD92
2012-01-01 to 2012-09-30155,330USD274
2011-07-01 to 2011-09-30-620USD92
2011-01-01 to 2011-09-30-13,334USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-668USD274
2011-01-01 to 2011-09-300USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-09-300USD274
2011-01-01 to 2011-09-300USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-09-300USD274
2011-01-01 to 2011-09-300USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-09-30-473,622USD
At 2011-12-31-628,952USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-07-01 to 2012-09-3020,006,402shares92
2012-01-01 to 2012-09-3020,006,402shares274
2011-07-01 to 2011-09-3020,006,402shares92
2011-01-01 to 2011-09-3020,006,402shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-07-01 to 2012-09-3020,159,001shares92
2012-01-01 to 2012-09-3020,159,001shares274
2011-07-01 to 2011-09-3020,159,001shares92
2011-01-01 to 2011-09-3020,159,001shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-07-01 to 2012-09-300USD/shares92
2012-01-01 to 2012-09-300.01USD/shares274
2011-07-01 to 2011-09-300USD/shares92
2011-01-01 to 2011-09-300USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-07-01 to 2012-09-300USD/shares92
2012-01-01 to 2012-09-300.01USD/shares274
2011-07-01 to 2011-09-300USD/shares92
2011-01-01 to 2011-09-300USD/shares273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-09-301,425USD
At 2011-12-31668USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-09-3020,006,402shares
At 2011-12-3120,006,402shares

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-09-301,425USD
At 2011-12-310USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-306,821USD92
2012-01-01 to 2012-09-3023,259USD274
2011-07-01 to 2011-09-30620USD92
2011-01-01 to 2011-09-3013,334USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-30603USD274
2011-01-01 to 2011-09-300USD273

Inspect the source

Entity
GREEN PLANET BIOENGINEERING CO., LTD. / CIK 0001392449
Captured
2026-09-20T07:59:33.158Z
SEC response SHA-256
2cbda3b6370ab7ee2977029c2cc808a0c03f7bdb233f3fbee0901bbee8f99b35

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001392449.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))